1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Greenwood, Indiana. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Greenwood.
Greenwood, Indiana has 1 SAMHSA-verified addiction treatment center offering 1 detox. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Treatment centers in Greenwood accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Bipolar disorder requires specific clinical management in Greenwood addiction-treatment settings: medication stabilization typically precedes deeper psychotherapy work, manic-phase substance use must be distinguished from continued substance use during depressive phases, and treatment planning accommodates the mood-cycling nature of the condition. Patients with bipolar disorder benefit from longer treatment episodes and more intensive aftercare than typical residential patients — relapse risk runs higher and clinical stabilization takes longer.
Adolescents in Greenwood access addiction treatment through pathways distinct from adult care: school-based counselor referrals, pediatrician referrals, juvenile justice system connections, and family-initiated admissions. The federally funded Adolescent Community Reinforcement Approach (A-CRA), Multidimensional Family Therapy (MDFT), and structured family-based interventions are first-line evidence-based options. Adult treatment settings are clinically inappropriate for adolescents and most Indiana jurisdictions require age-appropriate licensed providers.
Long-term medication management for Greenwood patients in recovery often extends well beyond program completion: MAT for opioid use disorder typically continues for years (or indefinitely) and is associated with sustained mortality reduction; naltrexone for alcohol use disorder is typically a 6-12 month course; psychiatric medications continue per indication regardless of recovery status. Outpatient prescribers in Greenwood familiar with addiction recovery patient populations provide continuity that general primary care often can't replicate.
Pre-authorization is the most common insurance friction for Greenwood patients entering residential addiction treatment. Insurers require clinical documentation that ASAM criteria for residential placement are met — specifically that lower-intensity outpatient care has been tried or is clinically insufficient, and that the patient's withdrawal risk, co-occurring conditions, or environmental factors require 24-hour structure. Treatment-provider clinical staff handle this documentation; patients can typically expect 24-48 hour authorization turnaround.
Documentation and consent at Greenwood program admission is structured to comply with 42 CFR Part 2 confidentiality of substance-use treatment records — a heightened standard above HIPAA. Patients typically sign multiple consent forms: treatment consent, releases for specific communications (with family, employer, legal contacts, other providers), and acknowledgments of program policies. These consents are revocable and patients retain control over disclosure of their treatment information except for narrow regulatory exceptions.
Greenwood sits within Indiana's broader addiction-treatment infrastructure — a network of licensed providers ranging from medically supervised detox facilities through residential treatment, partial hospitalization, intensive outpatient, and standard outpatient counseling. Patients seeking care in Greenwood have access to options at multiple intensity levels, with placement decisions driven by ASAM criteria: withdrawal risk, biomedical conditions, emotional/behavioral status, readiness to change, relapse potential, and the patient's current recovery environment. The specific providers verified for Greenwood below represent facilities that have been confirmed against SAMHSA's treatment-locator database and Indiana licensing records.
Medication-assisted treatment (MAT) for opioid use disorder is available in Greenwood through multiple pathways: federally certified Opioid Treatment Programs (OTPs) dispensing methadone, office-based buprenorphine prescribers (now expanded after the X-waiver elimination), and extended-release naltrexone (Vivitrol) at clinics willing to administer the monthly injection. Each medication has clinical use cases — methadone for severe long-standing opioid use disorder, buprenorphine for outpatient maintenance, naltrexone for patients fully detoxed and committed to abstinence-based recovery.